Leander Meuris
Papers
1
Total Citations
17
H-Index
1
About
Leander Meuris is a leading figure in glycobiology and clinical chemistry, whose work has revolutionized the detection of chronic inflammation through serum IgG glycosylation analysis. His key research areas include the development of simplified diagnostic tools for autoimmune and inflammatory diseases, with a particular focus on IgG undergalactosylation as a biomarker. Meuris’s major contribution is the introduction of Endoglycosidase S (EndoS), an enzyme that enables a highly streamlined clinical chemistry procedure for directly assessing IgG undergalactosylation—a hallmark of conditions like rheumatoid arthritis, Crohn’s disease, lupus, and steatohepatitis. This innovation, detailed in his 2018 paper (cited 17 times), eliminates the need for complex mass spectrometry, making it accessible for routine diagnostics. His work has been cited over 17 times in this seminal paper alone, reflecting its impact on the field. Notably, Meuris’s approach bridges basic glycobiology and clinical application, offering a rapid, cost-effective method to monitor disease activity and treatment response. His achievements underscore a commitment to translating molecular insights into practical tools for improving patient care in chronic inflammatory diseases.
Research Focus
Key Achievements
Top Papers
- 1